Publications by authors named "Marie-Claude Lalmand"

Unlabelled: Interferon regulatory factor 3 (IRF3) is an important transcription factor in Toll-like receptor 4 (TLR4) signaling, a pathway that is known to play a critical role in liver ischemia-reperfusion injury. In order to decipher the involvement of IRF3 in this setting, we first compared the intensity of hepatic lesions in IRF3-deficient versus wildtype mice. We found increased levels of blood transaminases, enhanced liver necrosis, and more pronounced neutrophil infiltrates in IRF3-deficient mice.

View Article and Find Full Text PDF

Galectins are a large family of proteins which bind galactoside-containing glycans. Their role in cancer seems to be important since members of the family may mediate cell adhesion and modulate cell growth. Galectin-3 (Gal-3) is expressed in the nucleus, in the cytoplasm and on the cell surface, and can also be secreted into the extracellular matrix.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Marie-Claude Lalmand"

  • - Marie-Claude Lalmand's research primarily investigates the role of specific proteins, such as interferon regulatory factor 3 (IRF3) and galectin-3 (Gal-3), in various pathological conditions, including liver injury and melanoma.
  • - One key finding indicates that IRF3 deficiency exacerbates liver ischemia-reperfusion injury, evidenced by heightened liver necrosis and inflammatory response in deficient mice compared to wildtype controls.
  • - In her studies on melanoma, Lalmand highlights the expression patterns of galectin-3 in both primary and metastatic lesions, suggesting its potential involvement in tumor biology by affecting cell adhesion and growth modulation.